BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
657 results:

  • 1. Association between being breastfed in infancy and adult colorectal cancer risk among Japanese men and women.
    Minami Y; Kanemura S; Kusaka J; Kinouchi M; Suzuki S; Iwasashi H; Nishino Y; Kakugawa Y; Miura K
    Sci Rep; 2024 Apr; 14(1):9661. PubMed ID: 38671142
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and Prognosis in Patients After Radical Resection of colorectal cancer].
    Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
    Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
    Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Precursor exhausted CD8
    Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
    Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
    Chen Q; Deng Y; Li Y; Chen J; Zhang R; Yang L; Guo R; Xing B; Ding P; Cai J; Zhao H
    Cancer Lett; 2024 Apr; 588():216778. PubMed ID: 38458593
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Underwater versus conventional endoscopic mucosal resection for ≥10 mm sessile or flat colorectal polyps: A systematic review and meta-analysis.
    Wang X; Wang Y; Cao X; Zhang C; Miao L
    PLoS One; 2024; 19(3):e0299931. PubMed ID: 38451998
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term Changes in Low Anterior Resection Syndrome in Survivors of Rectal cancer: Longitudinal Follow-up of a Randomized Controlled Trial.
    He S; Zhang J; Wang R; Li L; Sun W; Wang J; Deng Y; Liang W; Dou R
    Dis Colon Rectum; 2024 Jun; 67(6):834-840. PubMed ID: 38426539
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in colorectal cancer.
    Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.
    von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C
    Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in colorectal cancer.
    Elomaa H; Härkönen J; Väyrynen SA; Ahtiainen M; Ogino S; Nowak JA; Lau MC; Helminen O; Wirta EV; Seppälä TT; Böhm J; Mecklin JP; Kuopio T; Väyrynen JP
    Mod Pathol; 2024 Apr; 37(4):100450. PubMed ID: 38369188
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study.
    Wisse PHA; de Klaver W; van Wifferen F; van Maaren-Meijer FG; van Ingen HE; Meiqari L; Huitink I; Bierkens M; Lemmens M; Greuter MJE; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; Carvalho B; de Wit M; Meijer GA
    Lancet Oncol; 2024 Mar; 25(3):326-337. PubMed ID: 38346438
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.
    Murff HJ
    Ann Intern Med; 2024 Feb; 177(2):JC23. PubMed ID: 38316002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
    Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
    Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
    Filipas DK; Labban M; Beatrici E; Stone BV; Qian Z; D Andrea V; Ludwig TA; Reis LO; Cole AP; Trinh QD
    Vaccine; 2024 Jan; 42(3):441-447. PubMed ID: 38184391
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial.
    Arevalo M; Sutton SK; Abdulla R; Christy SM; Meade CD; Roetzheim RG; Gwede CK
    Cancer; 2024 May; 130(9):1684-1692. PubMed ID: 38150285
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Martin-Gallausiaux C; Salesse L; Garcia-Weber D; Marinelli L; Beguet-Crespel F; Brochard V; Le Gléau C; Jamet A; Doré J; Blottière HM; Arrieumerlou C; Lapaque N
    Gut Microbes; 2024; 16(1):2295384. PubMed ID: 38126163
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Altered insulin sensitivity and immune function in patients with colorectal cancer.
    Baban B; Eklund D; Tuerxun K; Alshamari M; Laviano A; Ljungqvist O; Särndahl E
    Clin Nutr ESPEN; 2023 Dec; 58():193-200. PubMed ID: 38057005
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
    Bauer TM; Santoro A; Lin CC; Garrido-Laguna I; Joerger M; Greil R; Spreafico A; Yau T; Goebeler ME; Hütter-Krönke ML; Perotti A; Juif PE; Lu D; Barys L; Cremasco V; Pelletier M; Evans H; Fabre C; Doi T
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030303
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
    Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
    Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.